fashion -WSS

fashion

author：knowledge 2025-09-29 16:45:17 - browse：88528

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： WuXi Biologics execs register to lobby as Congress comes for the company

focus

WSS

As H5N1 spreads in cows, experts warn against drinking raw milk

As H5N1 spreads in cows, experts warn against drinking raw milk

CVS is willing to dump 10% of its Medicare Advantage members

The United States must get value

STAT reporters are Pulitzer Prize finalists for investigative reporting

Ripples from Flovent's discontinuation is killing children with asthma

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Peter Hotez and the public health issue of online harassment

ALS treatment from Biogen, Ionis fails in study

Heart attack and stroke risk calculators need revising

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

After affirmative action ruling, medical educators look to 'holistic review'

HHS suspends federal funding for EcoHealth Alliance

Bright Health sells Medicare Advantage business to Molina

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

At least 13 dead in Texas as scorching temps continue

WuXi Biologics beefs up its lobbying operation

leisure time

Fertility clinic egg and embryo storage is a disaster

STAT series 'Denied by AI' wins major journalism prizes

Hottest summer in 2,000 years puts focus on extreme heat, health

Supreme Court to hear if Covid misinformation is protected speech

Abbott's new stent may help patients with peripheral artery disease

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

leisure time

hotspot

focus

leisure time